Search results
Results from the WOW.Com Content Network
Missandei is a former slave who comes into the service of Daenerys Targaryen during the latter's conquest of Essos. She serves as Daenerys' interpreter and is one of her most trusted counselors throughout the series. Missandei is portrayed by Nathalie Emmanuel in the HBO television adaptation, where her role is greatly expanded from that in the ...
Daenerys Targaryen (/ d ə ˈ n ɛər ɪ s t ɑːr ˈ ɡ ɛər i ə n / də-NAIR-iss tar-GAIR-ee-ən) [2] is a fictional character in the series of epic fantasy novels A Song of Ice and Fire by American author George R. R. Martin. She is a prominent point-of-view character, and is one of the series' most popular characters.
In the novels and the TV series, "khaleesi" is not a name, but the title of the wife of a "khal" (warlord) in the Dothraki language, held by Daenerys Targaryen. [362] Other names from characters in the series, like Daenerys, also became popular baby names. [363] [364] Game of Thrones has also become a subject of both academic and scientific ...
The Office of Rare Diseases Research was established in 1993 within the Office of the Director of the NIH. Its responsibilities were mandated by statute by the Rare Diseases Act of 2002. [2] [3] In 2011, the office became part of the newly created NCATS. [4] ORDR is currently headed by Dr. Anne R. Pariser, who took over the position in February ...
The South Texas Center for Emerging Infectious Diseases (STCEID) was founded by the University of Texas at San Antonio at the former Brooks Air Force Base site in San Antonio, TX. Intended to become one of the preeminent centers for biodefense research in the nation to provide some assistance to the Centers for Disease Control and Prevention (CDC).
Aegon II Targaryen. Aegon II Targaryen is the first-born son of Viserys and his second wife, Alicent Hightower. Since he is the oldest boy in the family, he believes he has the right to be the ...
In his final moments, “House of the Dragon’s” King Viserys was, well, not quite himself. Enfeebled and riddled with disease, his final words were spoken in an empty, darkened room.
The following is a timeline of the Rare Diseases Clinical Research Network: As a result of the Rare Diseases Act of 2002, on February 27, 2003, the ORDR (in conjunction with the National Center for Research Resources (NCRR), the General Clinical Research Consortium (GCRC) Program, and other NIH Institutes) requested applications for a Rare Diseases Clinical Research Network.